The Cannabis plant contains many types of compounds; however, one type of compound that has received more attention in 2025 than ever before is CBG (cannabigerol) also known as the “mother cannabinoid.” Although THC and CBD have been at the center of the conversation for many years, CBG is receiving much attention today because of its potential for therapeutic use and the growing number of cannabis products containing CBG. Therefore, what is CBG and why is it so well known in 2025? In order to understand, we must look deeper.
What is CBG?
CBG is a non-psychoactive cannabinoid contained within the cannabis plant. For years, THC and CBD were the most talked-about cousins of CBG. However, when considering the origin of these three cannabinoids, there is no question that CBG is the mother cannabinoid. When cannabis is first grown, it starts off as CBGA (cannabigerolic acid). Over time, CBGA breaks down into all the possible combinations of the aforementioned three cannabinoids. One of the reasons that CBG has stayed in the background is that the average amount of CBG present in cannabis plants is very small (usually below 1%), and therefore was rarely discussed prior to the past few years.
Why is CBG so Popular Now?
Although the cannabis industry has grown rapidly over the years, and while this rapid growth has created more awareness regarding the lesser-known cannabinoids such as CBG, the majority of the reason for this awareness is the result of research and anecdotal evidence of the numerous health benefits of CBG. There are several reasons that everyone is discussing CBG in 2025. These reasons include:
- Potential Therapeutic Use. One of the primary reasons that CBG is being spoken about today is because of the potential therapeutic uses of CBG. Specifically, CBG appears to have a broad spectrum of potential therapeutic uses.
- Anti-Inflammatory Properties. Studies indicate that CBG may aid in reducing inflammation and potentially helping to alleviate symptoms associated with chronic inflammatory conditions such as arthritis or muscle pain.
- Neuroprotective Properties. CBG may aid in protecting the brain from damage and could be helpful in treating neurodegenerative diseases such as Parkinson’s disease and Alzheimer’s disease.
- Appetite Stimulation. Although THA stimulates appetite, CBG may help to increase appetite in certain situations. This could be advantageous for individuals suffering from appetite-reducing side effects of medications (such as chemotherapy or anorexia).
Non-Psychoactive
Like CBD, CBG is non-psychoactive. Non-psychoactive means that it produces no “high” or intoxicating effects. This characteristic is attractive to those who wish to enjoy the potential health benefits of cannabis without experiencing the psychoactive effects of THC. Because CBG is non-psychoactive, it may be consumed during the day without affecting daily functioning. Therefore, it may be an excellent choice for individuals requiring long-term relief from symptoms.
Growing Market and Increased Consumer Interest
As consumers become better informed about the various cannabinoids, there is a greater desire to consume products that contain CBG. Due to this, product manufacturers are producing an increasingly large number of CBG-containing products. Products currently available include oils, capsules, topicals, and edibles.
Increased Support from Research
While research on CBG is in the early stages, studies are providing new information regarding the potential therapeutic applications of CBG. Clinical trials, animal studies, and laboratory research have demonstrated the therapeutic potential of CBG to treat a wide array of medical conditions, including gastrointestinal disorders and mental health disorders.
How is CBG Different Than CBD and THC?
Although CBG shares similar characteristics with CBD and THC, each cannabinoid has distinct characteristics that differentiate them from each other.
- CBG vs. THC: CBG is non-psychoactive. This means it will not induce a “high,” whereas THC is primarily responsible for the euphoric effects of marijuana, although it has therapeutic benefits. CBG is focused on anti-inflammatory and neuroprotective effects rather than euphoric effects.
- CBG vs. CBD: Both CBD and CBG are non-psychoactive and share a variety of therapeutic benefits. However, CBG has the additional benefit of supporting the overall health of the body, specifically the brain and digestive system.
Conclusion
CBG, the “mother cannabinoid,” is rapidly becoming a major player in the cannabis industry. Due to its ability to potentially treat a wide array of medical conditions, including neurodegenerative diseases, inflammation, and pain, along with its non-psychoactive properties, CBG provides a promising alternative to those who seek the medicinal benefits of cannabis without the psychoactive effects of THC. As the industry continues to grow and develop, CBG will continue to be a topic of discussion in the cannabis community. If you’re interested in learning more about CBG, be sure to keep up to date as more products and research becomes available.